Beta-carbolines cell cycle protein related kinase 2 inhibitor and use thereof

The invention relates to the field of pharmacochemistry, in particular to beta-carboline alkaloids (I), and methods for preparing the same, pharmaceutical compositions containing the same and the pharmaceutical uses of the same, especially the use of the compounds as cyclin-dependent kinase 2 inhibitors.